MedTrace Logo

Moxibustion for Primary Dysmenorrhea

NCT01972906 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2014-12-02

No results posted yet for this study

Summary

Hypothesis: Moxibustion is effective for managing primary dysmenorrhea. Aim: To attest the effectiveness and safety of moxibustion for primary dysmenorrhea. Design: A randomized controlled trial. 152 participants will be included. Two arms: moxibustion treatment group and ibuprofen control group.

Conditions

  • Primary Dysmenorrhea

Interventions

DEVICE

moxibustion

apply moxibustion according to traditional Chinese medicine

DRUG

Ibuprofen Sustained Release Capsules

apply Ibuprofen (H20013062), 0.3g， Bid, lasting 3 days before menstrual cycle

Sponsors & Collaborators

  • Chengdu University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Fanrong Liang, Professor · Chengdu University of TCM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-02-28
Completion
2014-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01972906 on ClinicalTrials.gov